BANK OF AMERICA CORP /DE/ - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2238
-91.9%
0.00%
Q3 2022$0
-100.0%
470
-39.4%
0.00%
Q2 2022$1,000
-90.0%
776
-72.1%
0.00%
Q1 2022$10,000
-37.5%
2,779
+27.8%
0.00%
Q4 2021$16,0002,1740.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders